What is the global market size of Airway Management Devices Market?

Airway Management Devices Market size was valued at USD 2 billion in 2022 and is poised to grow from USD 2.32 billion in 2023 to USD 3.62 billion by 2030, at a CAGR of 7.7% during the forecast period (2023-2030).

Who are the key vendors in the Global Airway Management Devices Market?

The existence of several major manufacturers competing for a sizable market share defines the competitive landscape of the airway management devices industry. To improve their market position, the businesses concentrate on developing innovative products, forming strategic alliances, and making acquisitions. They make significant investments in R&D to bring forth technologically cutting-edge and user-friendly airway management equipment. The businesses also participate in marketing campaigns and distribution alliances to broaden their reach internationally and boost their clientele. Additionally, new firms are entering the market, which increases competition. 'Medtronic (United States)', 'Smiths Medical (United States)', 'Teleflex Incorporated (United States)', 'Ambu A/S (Denmark)', 'Intersurgical Ltd. (United Kingdom)', 'Vyaire Medical Inc. (United States)', 'Medline Industries, Inc. (United States)', 'Flexicare Medical Limited (United Kingdom)', 'Mercury Medical (United States)', 'SunMed (United States)', 'Armstrong Medical Ltd. (United Kingdom)', 'Salter Labs (United States)', 'VBM Medizintechnik GmbH (Germany)', 'Medisize (Flex Ltd.) (United States)', 'Verathon Inc. (United States)', 'Intlock (Israel)', 'KARL STORZ SE & Co. KG (Germany)', 'UE Medical Devices Pvt. Ltd. (India)', 'Well Lead Medical Co., Ltd. (China)', 'Airways Corporation (India)'

What is the key driver of Global Airway Management Devices Market?

The rising prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, is a significant driver for the airway management devices market. These conditions necessitate the use of airway management devices for effective treatment and management.

What is the key market trend for Global Airway Management Devices Market?

In recent years, the market has experienced a number of significant market trends. The demand for sophisticated airway management systems with improved features and functions is one obvious trend. During airway procedures, these gadgets are intended to increase patient safety and deliver better results. The increasing use of video laryngoscopes, which provide better visualization and precision during intubation procedures, is another noteworthy trend. Additionally, due to their simplicity of use, speedy insertion, and low risk of problems, supraglottic airway devices are being used more frequently on the market. To reduce the chance of cross-contamination and guarantee infection control, there is also a move towards disposable airway management tools.

Which region accounted for the largest share in Airway Management Devices Market?

North America dominated the global market in 2022 and is projected to remain the fastest growing region during the forecast period, due to the prevalence of asthma and chronic obstructive pulmonary disease, as well as the increase in the elderly population. The U.S. Census Bureau reports that as of 2017, more than 50 million Americans aged 65 and older were at the highest risk of developing chronic conditions. In North America, two important countries where such airway management devices have been widely adopted are the U.S. and Canada. The main causes of the rising need for airway management devices market forecast in North America are the rise in pollution rate and the increase in occurrences of respiratory problems, even in neonatal care. Increase in healthcare R&D spending, and the rising incidence of chronic diseases such as COPD, the U.S. market will experience considerable expansion during the forecast period due to favorable reimbursement policies.

Airway Management Devices Market Size

Airway Management Devices Market Insights

Airway Management Devices Market size was valued at USD 2.15 Billion in 2023 and is poised to grow from USD 2.32 Billion in 2024 to USD 4.19 Billion by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).

Surging prevalence of respiratory disorders around the world is forecasted to drive up the sales of airway management devices in the future. Increasing of volume of surgical procedures performed globally owing to the hike in the incidence of multiple chronic and infectious diseases will also promote airway management devices market growth in the coming years. Rising investments in the research and development of new airway technologies and devices around the world are also expected to create new opportunities for airway management device companies in the long run. Growing cases of accidents and trauma are also bolstering the demand for emergency care services, which is also expected to benefit the airway management devices demand outlook in the future. Increasing need for anesthesia services across multiple healthcare establishments and increasing geriatric population are also estimated to bolster sales of airway management devices in the long run. However, the risk of cross-contamination due to reusability, high costs of advanced airway management devices, and risk of complications and infections are slated to be key restraints for airway management device companies across the study period and beyond.

US Airway Management Devices Market is poised to grow at a sustainable CAGR for the next forecast year.

FAQs

Airway management device companies should focus on launching new products to stay competitive in the global market. Collaborations, acquisitions, and mergers are expected to be key strategies for leading airway management device providers looking to expand their market presence. Countries with developed healthcare infrastructure will spearhead the sales of airway management devices as per this airway management devices market analysis. 'Medtronic ', 'ICU Medical, Inc. ', 'Teleflex Incorporated ', 'Ambu A/S ', 'Convatec Group PLC ', 'Karl Storz SE & Co. KG ', 'Flexicare (Group) Limited ', 'Intersurgical Ltd. ', 'SunMed LLC ', 'Vyaire ', 'VBM Medizintechnik GmbH ', 'Verathon Inc. ', 'SourceMark ', 'Mercury Enterprises ', 'Atos Medical ', 'P3 Medical ', 'Henan Tuoren Medical Device Co., Ltd. ', 'Mederen Neotech Ltd. ', 'Bomimed ', 'Medis Medical (UK) Ltd. ', 'Olympus Corporation ', 'Armstrong Medical Ltd. (Eakin Healthcare Group) ', 'Nihon Kohden Corporation ', 'Shenzhen Hugemed Medical Technical Development Co., Ltd. ', 'Venner Medical Medizintechnik'

Increasing air pollution and growing number of smokers around the world have contributed to a high incidence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea. Airway management devices play a crucial role in the treatment of these disorders thereby their high occurrence will drive market growth in the future.

Use in Home Care Settings: Airway management device manufacturers should focus on the development of products that are suitable for home care use. Portable CPAP (continuous positive airway pressure) machines and nebulizers that can be used in home care environments will be high in demand for preference for home care among elderly increases rapidly in most parts of the world.

North America is forecasted to secure the top spot in the global airway management devices market forecast. Rising prevalence of chronic respiratory disorders, availability of favorable reimbursement policies, and high volume of surgeries performed in this region are helping it maintain its dominant stance on a global level. Canada and the United States are forecasted to emerge as the most opportune markets for airway management device suppliers operating in this region. High investments in R&D of advanced airway management devices and quick adoption of these novel technologies will also help North America remain the most opportune market for all airway management device providers through 2031 and beyond.